The passage of leukocytes across the endothelium and into arterial walls is a critical step in the development of atherosclerosis. Previously, we showed in vitro that the RhoG guanine nucleotide exchange factor SGEF (Arhgef26) contributes to the formation of ICAM-1-induced endothelial docking structures that facilitate leukocyte transendothelial migration. To further explore the in vivo role of this protein during inflammation, we generated SGEF-deficient mice. When crossed with ApoE null mice and fed a Western diet, mice lacking SGEF showed a significant decrease in the formation of atherosclerosis in multiple aortic areas. A fluorescent biosensor revealed local activation of RhoG around bead-clustered ICAM-1 in mouse aortic endothelial cells. Notably, this activation was decreased in cells from SGEF-deficient aortas compared to wild type. In addition, scanning electron microscopy of intimal surfaces of SGEF 2/2 mouse aortas revealed reduced docking structures around beads that were coated with ICAM-1 antibody. Similarly, under conditions of flow, these beads adhered less stably to the luminal surface of carotid arteries from SGEF 2/2 mice. Taken together, these results show for the first time that a Rho-GEF, namely SGEF, contributes to the formation of atherosclerosis by promoting endothelial docking structures and thereby retention of leukocytes at athero-prone sites of inflammation experiencing high shear flow. SGEF may therefore provide a novel therapeutic target for inhibiting the development of atherosclerosis.
Introduction
Atherosclerosis is characterized by the successive influx of proinflammatory monocytes and lymphocytes into the arterial wall resulting in localized inflammation, accumulation of lipids, fibrosis and cell death. These regions of local thickening are known as atherosclerotic plaques [1] . ICAM-1 is a prominent endothelial cell surface receptor for leukocyte recruitment and studies in mice have shown that interfering with the function of this receptor reduces the formation of atherosclerotic lesions [2] [3] [4] . Previously, we found that ICAM-1 clustering on endothelial cells relocates the Rho guanine nucleotide exchange factor (GEF) SGEF to the plasma membrane where it leads to activation of the Rho family GTPase RhoG [5] . Subsequently, RhoG activation contributes to the formation of actin rich protrusions on the dorsal surface of endothelial cells [5] , known as transmigratory cups or docking structures [6;7] . These cups are thought to serve as intermediate docking structures that provide mechanical support for adhered leukocytes before transmigration (reviewed in [8;9] ). However, it is not known if these structures are involved in pathology such as atherosclerosis. Also, whether Rho-GEFs in general are involved in this process is unclear. Using SGEFdeficient and wildtype mice, we show here that SGEF contributes to the progression of atherosclerosis. Examining the interaction of beads coated with antibodies against ICAM-1, we find that although initial adhesion of the beads to the walls of isolated arteries is identical in the SGEF null mice, exposure to flow dislodges more beads from SGEF null than from wildtype arteries. Consistent with these results, the SGEF null vessels and endothelial cells reveal lower RhoG activation and decreased docking structure formation than their wildtype counterparts. Our results suggest that the reduced formation of docking structure in mice lacking SGEF contributes to the decreased susceptibility of these mice to develop atherosclerosis.
Results
Since silencing RhoG or SGEF respectively were shown to reduce leukocyte transmigration in a tissue culture model [5] , we hypothesized that deficiency of SGEF in mice would also affect inflammatory responses by interfering with the proper formation of apical cup structures. To test this hypothesis, we generated a mouse line deficient in SGEF. In vitro over-expression experiments using a mutated SGEF expression construct indicated that deletion of a cDNA stretch encoded by exons 4/5 of the murine SGEF gene, resulted in a non-functional protein ( Figure 1A ). Based on this, we generated mice that lack exons 4 and 5 of the mouse SGEF gene ( Figure 1B-D) . Intercrossing of heterozygote animals (SGEF +/2 ) resulted in all three possible genotypes, indicating that SGEF deficiency did not have lethal consequences during embryogenesis. Animals of all genotypes and gender are viable and fertile and do not show differences in leukocyte counts (Table S1 ) or other obvious phenotypes (followed up to 18 months of age). Genotype ratios of offspring after crossing SGEF +/2 animals matched the expected Mendelian distribution and did not suggest an embryonic lethal phenotype ( Figure S1 ). RT-PCR analysis showed that mutated SGEF mRNA isolated from SGEF 2/2 mice was still detectable (Figure 2A ). However, sequencing and expression of the SGEF cDNA cloned from SGEF 2/2 mice showed that the introduced mutation led to a frame shift proximal to the DH domain, resulting in the expression of a protein fragment that lacked GEF activity. This was confirmed by immunofluorescence experiments that showed that SGEF-D4/5 did not induce typical dorsal ruffles, whereas the full length construct did, as was also shown previously by our group [10] (Figure 2B ). Also biochemical studies showed that SGEF-D4/ 5 was unable to activate endogenous RhoG, whereas full length SGEF did ( Figure 2C ). Furthermore, when using a polyclonal anti-SGEF antibody directed to the N-terminus that recognizes the mutated form of SGEF expressed exogenously by HeLa cells, we did not detect any SGEF protein fragment in Western blots of organ lysates from SGEF 2/2 mice ( Figure 2D ). These data show that mutated SGEF mRNA is subject either to nonsense mRNAmediated decay or that any expressed truncated SGEF protein is highly unstable. Taken together, deletion of exons 4/5 of the SGEF gene resulted in animals that are completely devoid of any functional SGEF protein.
Leukocyte recruitment and transmigration through the endothelial cell layer into the vessel wall is a key step for the formation of atherosclerotic lesions [11] [12] [13] . Because ICAM-1 deficiency was previously found to protect from atherosclerosis in mice [2] [3] [4] and because SGEF acts downstream of ICAM-1 to facilitate the formation of docking-structures on endothelial cells [5] , we sought to investigate the role of SGEF in a mouse atherosclerosis model. We generated experimental groups of SGEF +/+ ApoE 2/2 and SGEF 2/2 ApoE 2/2 mice ( Figure 3A ). SGEF Figure 4E ). Importantly, total body mass, triglyceride and cholesterol levels did not differ between the two experimental groups ( Figure S2A-C) . In parallel experiments, we measured the percentage of ORO stained areas when the atherosclerotic stimulus was reduced by feeding a regular chow diet instead of a Western Diet. Under these conditions, we observed a slight reduction of stained plaque areas in SGEF Figure 5A-B) . However, the reduction under this dietary condition was not statistically significant. Therefore, these data indicate that SGEF deficiency had most impact on the development of atherosclerosis when animals were exposed to a diet containing high cholesterol and high fat. It is noteworthy that studies on the influence of ICAM-1 deficiency during atherosclerosis in mice similarly found that certain experimental conditions (specifics of the diet, mouse background strain, age of study animals) did not result in significant plaque reductions [2;13] .
To study if SGEF expression in hematopoietic cells, we isolated these cells from wildtype animals and permeabilized them to measure SGEF expression intracellularly using flow cytometry, since the limited number of cells did not allow us to quantify SGEF expression with Western blotting. We used isotype control antibodies as well as the SGEF-deficient leukocytes as threshold for the SGEF antibody staining. The data showed that SGEF was not expressed in murine hematopoietic cells, indicating that other cells were responsible for the reduced plaque formation in SGEFdeficient animals ( Figure S3 ). Our previous work showed that RhoG is a major target of SGEF and mediates the formation of dorsal ruffles [10] . Additionally, our group showed that RhoG activation and formation of endothelial docking structures after ICAM-1 clustering was reduced when SGEF was silenced [5] . Therefore, we determined if RhoG activation upon ICAM-1 clustering was perturbed in SGEF-deficient murine endothelial cells. Primary cells from the intima of mouse aortas from SGEF +/+ and SGEF 2/2 animals were isolated and subjected to magnetic cell-sorting for ICAM-2 expression. When cultured on fibronectincoated surfaces, these cells (hereafter referred to as mouse aortic endothelial cells, MAECs) formed monolayers of elongated cells ( Figure S4 ). Western blotting revealed that TNF-a-stimulated MAECs expressed ICAM-1 and VE-Cadherin, whereas the ICAM-2-negative cell population did not ( Figure 6A ), confirming the endothelial identity of the isolated MAECs. Due to the limited number of endothelial cells that can be isolated from mouse aortas, biochemical pull down assays using GST-ELMO to measure RhoG.GTP levels were not feasible. Therefore, through adenoviral delivery, YFP-tagged ELMO fragment was expressed in MAECs. Since ELMO is a specific downstream effector of RhoG, ELMO-YFP recruitment was measured as a read-out of local RhoG activation, similar to what has been described for local Rac1 activity upon phagocytosis [14] . TNF-a-stimulated primary MAECs from wildtype and SGEF-deficient animals were overlaid with polystyrene beads, coated with anti-ICAM-1 antibodies (hereafter: anti-ICAM-1 beads). When anti-ICAM-1 beads attached to the endothelium, time-lapse image acquisition was started. A representative example of ELMO-YFP recruitment to attached beads is shown in Figure 6B and supplemental movies (Movie S1 and S2). Quantification revealed reduced recruitment of ELMO-YFP to regions of attached beads in SGEF 2/2 MAECs compared to SGEF +/+ cells ( Figure 6C ). Significant reduction in fluorescence intensity was measured in MAECs derived from SGEF 2/2 compared to MAECs from SGEF +/+ mice at all time points between 0 and 60 minutes after bead attachment ( Figure 6D ).
Our previous work showed that silencing of SGEF specifically affected ICAM-1-mediated formation of docking structures around adhered leukocytes [5] . Therefore, we examined if SGEF-deficiency in mice decreased docking structure formation on endothelial cells in situ. Aortas were isolated from SGEF +/+ and SGEF 2/2 mice as described in the Methods section and stimulated with TNF-a overnight. Next, anti-ICAM-1 beads were allowed to adhere to the endothelial surface of the aortas for 2 hours. Scanning electron microscopy (EM) analysis revealed that the aortic intima, i.e. the endothelium, from wildtype animals induced membrane protrusions around adherent beads, whereas the aortic endothelium from SGEF 2/2 animals showed minimal protrusion activity in response to the beads ( Figure 7A ). Figure 7B ). Importantly, no differences were observed between the genotypes when beads coated with anti-VCAM-1 or nonspecific IgG1 antibodies were used ( Figure S5A and S5B) . When the total number of anti-ICAM-1 beads that were attached to aortas (independent of membrane protrusions) was counted, no difference in bead number between aortas isolated from SGEF +/+ and SGEF 2/2 animals was detected ( Figure S5C ). These data indicated that adhesion to endothelial ICAM-1 under static conditions was not affected by SGEF-deficiency. However, it has been proposed that docking structures provide mechanical support for leukocytes to resist flow forces during adhesion [15;16] . Therefore, anti-ICAM-1 beads were injected into the lumen of isolated intact carotid arteries that were attached to a perfusion system, as described in the Materials and Methods section. Next, the arteries were continuously perfused with 5 dynes/cm 2 for 5 minutes. Data from the literature shows that the shear rates in arteries are usually 10 dynes/cm 2 Figure 7C ). Beads coated with an IgG1-isotype control antibody adhered very poorly under flow conditions ( Figure 7C ). We wish to acknowledge that our set-up did not allow the perfusion of isolated immune cells over the arteries, due to firm adhesion of leukocytes to the inner surface of the cannula, resulting in obstruction. Taken together, these results showed that the formation of functional docking structures upon ICAM-1 clustering is strongly reduced in SGEFdeficient arteries.
Discussion
In this study, we have implicated a Rho GEF, SGEF, in the formation of atherosclerosis in vivo. Our data show a significant reduction in atherosclerotic lesions in the aortas of SGEF-deficient mice when fed a Western diet. At the molecular level, we show that SGEF-deficiency decreased RhoG activation and the formation of docking structures in response to ICAM-1 clustering. Rahaman and colleagues have shown that the Rho-GEF Vav1 is involved in the formation of foam cells and thereby contributes to the development of atherosclerosis [19] . To our knowledge, this is the first description of an endothelial Rho GEF involved in the formation of atherosclerosis. SGEF was targeted by deleting exon 4 and 5. Overexpressing this truncated form of the protein showed no functionality. Moreover, using SGEF specific antibodies that recognize the truncated form, we found that the mutant protein was not translated in mice. Therefore, we concluded that the SGEF deletion strategy resulted in mice that did not show any offtarget phenotypes. Atherosclerosis is nowadays recognized as an inflammatory disease [20] . Inflammation is characterized by activated leukocytes that extravasate from the vessel into the underlying tissue. During the development of atherosclerosis, this process occurs inappropriately [21] . Monocytes are the first immune cells that are detected in early atherosclerotic lesions [1] . In this study, mice deficient for SGEF in all cell types are generated. Therefore, the reduced plaque areas that were detected in SGEF-deficient mice could potentially also be the result of less infiltrated leukocytes, in particular monocytes, due to the lack of SGEF in these cells. SGEF is expressed in epithelial and endothelial cells [5;10] but we have not detected in mouse monocytes or neutrophils. In previous work, no expression was detected in HL60 and U937 cells [10] . These cells are hematopoietic precursor cells for neutrophils and monocytes, respectively. These data suggest that primary monocytes and neutrophils are devoid of SGEF expression and indicate that the decrease in atherosclerotic plaques in the SGEF-deficient animals is due to the absence of SGEF in endothelial cells rather than in monocytes.
Recent studies have shown that the endothelium actively participates in the extravasation process by inducing docking structures [5-7;21;22] . These are characterized by membrane protrusions, also known as dorsal membrane ruffles that extend from the apical surface of the endothelium. The small GTPases Rac1 and in particular RhoG are recognized for their ability to induce these type of membrane extension [10] . Also during leukocyte binding to the endothelium, Rac1 and RhoG are activated [23] . Our work indicated that reduction of RhoG expression represses the ability of the endothelium to induce dorsal ruffles and, as a consequence, also the formation of docking structures around adherent leukocytes [23] . Additional experiments indicate that the RhoG-specific Rho-GEF SGEF is responsible for the GTP exchange on RhoG in these endothelial cells during leukocyte adhesion and transmigration [5] . Our data presented here show that endothelial cells from aortas that lack SGEF compared with wildtype endothelial cells fail to induce these typical docking structures. Notably, we found that the SGEF2/2 aortas were less able to retain beads coated with anti-ICAM-1 under conditions of flow. This is consistent with the docking structures normally functioning to prevent leukocytes from being washed away from regions of inflammation. Together, these data indicate that the reduced lesion area in SGEF-deficient animals is most likely due to the inability of the endothelium to induce docking structures that actively retain leukocytes against the forces of blood flow thereby assisting their crossing of the vessel wall.
Our data suggest that SGEF may be an attractive pharmacological target for decreasing atherosclerosis, since we have not observed any negative phenotypes in mice that lack SGEF. An SGEF-based pharmacological prevention strategy is further supported by studies showing that ICAM-1 deficiency also results in reduced atherosclerosis [2] [3] [4] . Therapies targeting ICAM-1 are an interesting approach; however, adverse effects were found when anti-ICAM-1 antibodies were used in a phase III clinical study with ischemic stroke patients [24] . In general, antibodybased therapies targeting cell surface receptors involve serious side effects [25] and are less appropriate for long term applications such as treatment of atherosclerosis. Additionally, ICAM-1 is involved in acute host defense, and therefore increased susceptibility to infectious organisms is an intrinsic side effect of targeting this receptor [26] . Developing therapeutic drugs targeting SGEF function may avoid these problems.
Materials and Methods

Mice
To build a targeting construct for the murine SGEF gene, the pOSfrt-loxP vector was used (kindly provided by Dr. Oliver Smithies and the UNC Animal Model Core Facility). Mouse genomic areas were amplified by PCR. The short arm: (3039 bp, starting 470 bp downstream of exon 5; ending 3509 bp downstream of exon 5) was cloned into the BamHI/NotI sites of the vector. A double stranded oligo-nucleotide representing the second LoxP site and an FseI site was introduced into the NheI/ClaI sites of the construct. The DNA fragment of the genomic area covering Exon 4/5 (4495, starting 624 bp upstream of exon 4 immediately after a genomic ApaI site; ending 467 bp downstream of exon 5) was cloned into the ClaI/FseI sites of the construct. Finally, the long arm (5412 bp, starting 6042 bp upstream of exon 4; ending 630 bp upstream of exon 4 immediately before a genomic ApaI site) was cloned via the NheI site of the construct and its orientation was checked by sequencing. For ES cell transfection, the construct was linearized by a NotI digest. ES cell transfections and blastocyst injection were performed by the UNC Animal Model Core Facility. ES cell clones that have integrated the construct into the genome through homologous recombination of the short and long arm were identified by Southern blotting. Two selected clones were then transfected with an expression construct for crerecombinase to delete exon 4/5, which was again confirmed by Southern blotting. These cells were used for blastocyst injection and the mutated allele was crossed out by breeding chimeras with wild type c57/black6 mice. Animals were crossed back to wild type c57/black6 mice over at least 7 generations. Wildtype c57/black6 mice (strain: C57BL/6J) and ApoE-deficient mice (strain: B6.129P2-ApoE tm1Unc /J) were obtained from Jackson Laboratories. Atherosclerosis study mice were either fed a regular chow diet ('Prolab RMH3000', LabDiet 6.4% fat, 195 ppm cholesterol) or a high fat diet ('Western Diet for Rodents', Testdiet, 19.9% fat, 1707 
Oil Red O (ORO) staining method
Mice were perfused with PBS followed by PBS/4% PFA. Dissected aortas were further fixed for 48 hours in PBS/4% PFA. After incubating the aortas in 75% ethanol the aortas were stained with 0.5% Oil Red O (ORO)/60% isopropanol. Images were taken of longitudinally opened aortas that were pinned down on wax. Images were taken with dissection microscope and a color camera. Percentage of ORO stained areas was determined with ImageJ software.
Antibodies and Reagents
The following antibodies were used: mouse anti-RhoG (clone 1F3, Millipore); rat-anti-mouse-ICAM2 (clone 3C4, BD-Pharmingen); rat-anti-mouse-ICAM1 (clone MAB796, R&D); mouse-anti-VE-Cadherin (clone F8, Santa Cruz), anti-VCAM-1 mAb (R&D), IgG1-isotype control Ab (Sanquin, Amsterdam, the Netherlands), anti-Myc mAb (Clone 9E10; Sigma) and secondary HRP Abs were from Dako (Denmark). Phalloidin-Alexa488 or Texas-red was purchased from Invitrogen. Endothelial tissue culture media EBM-2 (supplemented with EGM-2 SingleQuots TM ) was obtained from Lonza. DMEM media was obtained from Gibco. The following reagents were used: Oil Red O (Sigma); Heparin (Abraxis, 10000 USP units/ml); magnetic beads coated with sheep-anti-rat-IgG (Dynal); polystyrene beads 'Amino Microspheres' (Polyscience 3.0 mm carotid artery perfusion, 5 mm for biosensor experiments, 10 mm for aorta EM experiments). Proteins were bound to polystyrene beads according to the manufacturer's protocol followed by free glutaraldehyde group blocking with 0.5 M ethanolamine and 2 mg/ml BSA.
Isolation of Mouse Aortic Endothelial Cells
Mouse aortic endothelial cells (MAECs) were isolated by combining two modified protocols that have been described previously [27;28] . Briefly, adult mice (8 to 12 weeks old) were anesthetized and then perfused with PBS containing 20% FBS and 100 units heparin. The thoracic descending aorta was isolated (from end of descending arch to diaphragm) and put into a glass dish with the bottom covered with a layer of sterile wax. All subsequent dissecting steps were done in this dish under DMEM media. Remaining connecting tissue on the outside of the aorta was removed before the aorta was opened by a longitudinal cut. The opened aorta was pinned down with small needles with the intimal surface facing up. After removing the media, the pinned down aorta was overlaid with 0.5 ml of DMEM/Collagenase (2 mg/ml) at 37uC for 60 minutes. Subsequently, continuous flushing of the intima released the aortic endothelial cells which were then plated on collagen-I coated dishes. After two days, the cells were overlaid with magnetic Dynal beads that had been coated with anti-ICAM2 antibody. After 30 minutes the cells were trypsinized and sorted by a magnet, before the bead-bound cells were again plated on Collagen-1 coated dishes and used for experiments within the following 7 to 14 days.
Biosensor to Measure Local RhoG activation
To calculate local activation of RhoG in cells, a fluorescently tagged fragment of ELMO1 was used (ELMO-Ypet). The cDNA was cloned into pAd vector and adenovirus particles were produced in 293A cells ('ViralPower Adenoviral Expression System' from Invitrogen). Twenty-four hours post infection of MAECs; time-lapsed image stacks were acquired. Fluorescence was measured in a circular area (diameter 8.3 mm) around an attached bead. Fluorescence right before bead attachment was used as the baseline fluorescence.
Bead Adhesion Assay and Scanning Electron Microscopy of Mouse Aortas
Murine aortas were dissected using microsurgery, cut open longitudinally and kept overnight at 37uC at 5% CO 2 . In parallel, the samples were pretreated with 10 ng/mL murine TNF-alpha overnight. For scanning electron microscopy (scanning EM), 1 mg/ml of antibody-containing beads was washed and resuspended in EGM-2 medium. Next, the beads were incubated on an isolated murine aorta for 2 hours as indicated. After the appropriate time, unbound beads were removed, and samples were put on ice, gently washed three times with ice-cold PBS containing 1 mM Ca 2+ /Mg 2+ . Subsequently samples were fixed in 2.5% glutaraldehyde/PBS for 30 min at room temperature, and processed for scanning electron microscopy as described previously 6 . Cells were examined on a scanning electron microscope (model 820; JEOL) at 15 kV. Scanning EM analysis revealed the induction of docking structures as described in results section.
Perfusion assay
Specially-developed cannulae are placed on each end of an isolated carotid artery and EGM-2 medium, containing anti-ICAM-1 or IgG1-isotype Ab-coated beads, was added. Beads were allowed to adhere for 30 minutes, followed by induction of flow at 5 dynes/cm 2 . After 5 minutes, arteries were fixed using 3.7% formaldehyde, permeabilized using 0.2% Triton X-100, stained for F-actin using Texas-Red Phalloidin and nuclei using DAPI and analyzed by confocal laser scanning microscopy. Beads were visualized using DIC. Tile scan (363) images were recorded with a ZEISS LSM510 confocal microscope with appropriate filter settings and the number of beads was counted per tile scan. At least 3 tile scans were counted per experiment.
Statistical analysis
Statistical comparisons between experimental groups were performed by the 2-tailed Student's T-test with unequal variance. A 2-tailed p-value of ,0.05 was considered significant. 
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